Cost-of-illness studies: concepts, scopes, and methods
暂无分享,去创建一个
[1] M. Rayner,et al. The economic burden of coronary heart disease in the UK , 2002, Heart.
[2] K. Flegal,et al. Methods of calculating deaths attributable to obesity. , 2004, American journal of epidemiology.
[3] R. Kessler,et al. Costs of attention deficit–hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000 , 2005, Current medical research and opinion.
[4] L. Trupin,et al. A national study of medical care expenditures for respiratory conditions , 2002, European Respiratory Journal.
[5] M. Ryan. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. , 1999, Social science & medicine.
[6] J Raftery,et al. Perspectives in economic evaluation , 1998, BMJ.
[7] Michael E. Chernew,et al. Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] T. Hodgson. The state of the art of cost-of-illness estimates. , 1983, Advances in health economics and health services research.
[9] L L Kupper,et al. Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, CT. , 1980, International journal of epidemiology.
[10] Hodgson Ta. The state of the art of cost-of-illness estimates. , 1983 .
[11] R. Kessler,et al. The economic burden of anxiety disorders in the 1990s. , 1999, The Journal of clinical psychiatry.
[12] M. Drummond,et al. Cost-of-illness studies: a major headache? , 1992, PharmacoEconomics.
[13] Rice Dp. Cost of illness studies: what is good about them? , 2000 .
[14] M. Pauly. Valuing health care: Valuing health care benefits in money terms , 1995 .
[15] M. Johannesson,et al. The friction cost method: a comment. , 1997, Journal of health economics.
[16] J Benichou,et al. A review of adjusted estimators of attributable risk , 2001, Statistical methods in medical research.
[17] Ron Goeree,et al. The Valuation of Productivity Costs Due to Premature Mortality: A Comparison of the Human-Capital and Friction-Cost Methods for Schizophrenia , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[18] E. Finkelstein,et al. National medical spending attributable to overweight and obesity: how much, and who's paying? , 2003, Health affairs.
[19] P. Langley,et al. A review of cost-of-illness studies on obesity. , 1998, Clinical therapeutics.
[20] C. Weinberg,et al. Use and misuse of population attributable fractions. , 1998, American journal of public health.
[21] M. Reynaud,et al. Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). , 2001, Alcohol and alcoholism.
[22] M. Mugford,et al. Elementary Economic Evaluation in Health Care , 1998 .
[23] T. Hodgson,et al. Cost-of-illness methodology: a guide to current practices and procedures. , 1982, The Milbank Memorial Fund quarterly. Health and society.
[24] M A Koopmanschap,et al. The friction cost method for measuring indirect costs of disease. , 1995, Journal of health economics.
[25] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[26] T. Hodgson. Costs of illness in cost-effectiveness analysis. A review of the methodology. , 1994, PharmacoEconomics.
[27] D. Rice,et al. Cost of illness studies: what is good about them? , 2000, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.
[28] Ron Z. Goetzel,et al. Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers , 2004, Journal of occupational and environmental medicine.
[29] T. Hodgson,et al. Medical care expenditures for diabetes, its chronic complications, and its comorbidities. , 1999, Preventive medicine.
[30] V. Foster,et al. Valuing the Multiple Impacts of Pesticide Use in the UK: A Contingent Ranking Approach , 2008 .
[31] D. Pathak,et al. Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. , 1999, Clinical therapeutics.
[32] A. Miners. Estimating ‘Costs’ for Cost-Effectiveness Analysis , 2012, PharmacoEconomics.
[33] E. Finkelstein,et al. National medical expenditures attributable to overweight and obesity: How much and who's paying? , 2002 .
[34] H. Birnbaum,et al. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.
[35] M. Ward,et al. Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[36] Plamen Nikolov,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[37] P. Zarembka. Frontiers in econometrics , 1973 .
[38] M. Drummond. Cost-of-Illness Studies , 1992, PharmacoEconomics.
[39] B. Bloom,et al. Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making , 2012, PharmacoEconomics.
[40] Frank A. Sloan,et al. Valuing health care , 1996 .
[41] C. Donaldson,et al. Economics and obesity: costing the problem or evaluating solutions? , 2004, Obesity research.
[42] L. Trupin,et al. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care. , 2001, Arthritis and rheumatism.
[43] Per-Olov Johansson,et al. Evaluating Health Risks: An Economic Approach , 1995 .
[44] Rosanna Tarricone,et al. Cost-of-illness analysis. What room in health economics? , 2006, Health policy.
[45] H. Morgenstern,et al. Measures of Disease Incidence Used in Epidemiologic Research , 1980 .
[46] J. Mincer. Investment in Human Capital and Personal Income Distribution , 1958, Journal of Political Economy.
[47] F. Tediosi,et al. Costs of diabetes. A methodological analysis of the literature. , 1999, PharmacoEconomics.